Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.

Jessica ChuErika PanfenLinna WangAnthony MarinoXue-Qing ChenR Marcus FancherRaviraj LandageOmprakash PatilSalil Dileep DesaiDevang ShahYongjun XueMichael SinzHong Shen

Published in: Pharmaceutical research (2023)

ECD may allow an in-depth appraisal of the role of intestinal efflux transporter(s) in drug disposition in animals and humans through local intestinal drug interactions.

Keyphrases

emergency department